A trial to test an experimental drug in patients with head and neck cancer launches in the UK, through the Combinations Alliance – a joint initiative between Cancer Research UK and the Experimental Cancer Medicine Centres (ECMC) Network. Researchers want to find out whether using Astra Zeneca’s AZD1775 experimental compound, in combination with chemotherapy before surgery or with chemotherapy and radiotherapy after surgery, is more effective and reduces the risk of the cancer returning. They also want to find out if the combination of AZD1775 and chemotherapy before surgery decreases the need for further treatment after surgery.
See original article at: http://www.cancerresearchuk.org/about-us/cancer-news/press-release/2017-11-24-experimental-drug-trial-seeks-to-improve-treatment-for-head-and-neck-cancer
Post a comment